Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
Purpose The current standard therapy for patients with diffuse large B-cell lymphoma (DLBCL) is rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). The role of consolidative radiation therapy (RT) in the setting of R-CHOP chemotherapy is not well reported. This retros...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Published: |
2010
|
| Online Access: | http://hdl.handle.net/10725/2256 http://dx.doi.org/10.1200/JCO.2009.27.3441 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|